Absorbable Bone Regeneration Material "Verte" Receives Medical Device Approval [Nagoya University, Okayama University, Menicon]

May 6, 2026 Okayama University https://www.okayama-u.ac.jp/ ◆ Overview Nagoya University (Headquarters: Nagoya City, President: Sugiyama Nao), Okayama University (Headquarters: Okayama City, President: Yasutomo Nasu), and Menicon Co., Ltd. (Headquarters: Nagoya City, Representative Director and CEO: Koji Kawaura) are pleased to announce that their absorbable bone regeneration material "Verte" received new medical device approval in Japan on February 13, 2026. This medical device was developed using the results of joint research between the Department of Orthopedic Surgery, Graduate School of Medicine, Nagoya University and Menicon Co., Ltd., and the Department of Systems Physiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University and Menicon Co., Ltd. Approved this time, this medical device, which uses self-assembling peptide gel technology as a bone filler, is expected to contribute to the provision of better medical care by assisting bone regeneration in bone defects. This matter was released on April 7, 2026. ○ Medical Device Approval Number: 30800BZX00042000 ○ Name ・Generic Name: Absorbable Bone Regeneration Material ・Product Name: Verte ○ Class Classification: IV ○ Intended Use or Effect This product assists bone regeneration by implanting it in bone defects mixed with autologous bone. It is used in applications where the product itself is not subject to replacement loads and where it does not contribute to the initial fixation of implants. Department of Orthopedic Surgery/Rheumatology, Graduate School of Medicine, Nagoya University: Shiro Imagama, Hiroaki Nakashima, Sadayuki Ito, Kei Ando (at time of research) Okayama University, Academic Research Institute, Medical, Dental and Pharmaceutical Sciences (Medicine): Keiji Naruse ◆ For more detailed information Announcement of Medical Device Approval for Absorbable Bone Regeneration Material "Verte" https://www.okayama-u.ac.jp/up_load_files/press_r8/press20260407-1.pdf ◆ Contact for this matter ・Nagoya University Shiro Imagama Professor, Department of Orthopedic Surgery/Rheumatology, Graduate School of Medicine, Nagoya University General Affairs Division, Faculty of Medicine/Graduate School of Medicine, Nagoya University TEL: 052-744-2040 ・Okayama University Keiji Naruse Professor, Department of Systems Physiology, Academic Research Institute, Medical, Dental and Pharmaceutical Sciences (Medicine), Okayama University TEL: 086-235-7112 Public Relations Division, General Affairs Department, Okayama University TEL: 086-251-7292 ・Menicon Co., Ltd. External Affairs and Public Relations Department TEL: 052-935-1187 Okayama University Hospital, New Medical Research and Development Center 2-5-1 Shikata-cho, Kita-ku, Okayama City, Okayama 700-8558 Please inquire about relevant cases via the URL below: http://shin-iryo.hospital.okayama-u.ac.jp/ph_company/ Okayama University Hospital, Research Promotion Division, Industry-Academia-Government Collaboration Promotion Group 2-5-1 Shikata-cho, Kita-ku, Okayama City, Okayama 700-8558 TEL: 086-235-7983 E-mail: ouh-csnw◎adm.okayama-u.ac.jp *Please replace ◎ with @ http://shin-iryo.hospital.okayama-u.ac.jp/medical/ Okayama University Research & Innovation Co-creation Organization, Industry-Academia-Government Collaboration Headquarters 1-1-1 Tsushima Naka, Kita-ku, Okayama City, Okayama 700-8530, Okayama University Tsushima Campus, Main Building 1F TEL: 086-251-8463 E-mail: sangaku◎okayama-u.ac.jp *Please replace ◎ with @ https://www.orsd.okayama-u.ac.jp/ Okayama University Task Force for Strengthening and Promoting Shared Research Equipment (Abbreviation: Team Shared) 1-1-1 Tsushima Naka, Kita-ku, Okayama City, Okayama 700-8530, Okayama University Tsushima Campus, Main Building 1F TEL: 086-251-8705 FAX: 086-251-7114 E-mail: cfp◎okayama-u.ac.jp *Please replace ◎ with @ https://corefacility-pot